Xylazine (“Tranq”) and Fentanyl: What Families Need to Know

Xylazine, widely known in harm reduction circles as “tranq,” is a veterinary sedative that has become increasingly common in the illicit drug supply, almost always mixed with fentanyl. It is not a new drug, but its presence in the fentanyl supply is a recent development with serious implications for overdose response, wound care, and treatment.

If someone you love uses or is at risk of using illicit opioids, understanding xylazine is no longer optional. Tranq changes how overdoses present, it does not respond to naloxone, and it causes severe wounds that can lead to amputation if untreated. This guide explains what families need to know clearly and practically.

What Families Should Understand About Xylazine

• Xylazine is not an opioid and cannot be reversed by naloxone
• It is used as an adulterant in fentanyl to extend the drug’s effects
• Xylazine causes a much deeper sedation than fentanyl alone
• Characteristic wounds appear at injection sites and can spread rapidly
• Naloxone should still be used in xylazine-fentanyl overdoses because it reverses the fentanyl component
• The DEA has confirmed xylazine-fentanyl in the drug supply in all 50 US states

What Is Xylazine?

Xylazine is an alpha-2 adrenergic agonist approved for use in veterinary medicine as a sedative and muscle relaxant. It is used in large animals, particularly horses and cattle, for surgical procedures. It has never been approved for human use, in any dose, for any purpose.

When combined with fentanyl, xylazine extends and deepens the sedation that fentanyl produces. Drug suppliers add it to fentanyl for this reason: it makes the drug feel stronger and last longer, which increases its appeal in the illicit market. The problem is that xylazine’s effects cannot be reversed by naloxone, which means standard overdose response is only partly effective when xylazine is present.

How Xylazine Changes an Overdose

In a standard fentanyl overdose, the biggest danger is respiratory depression. Fentanyl suppresses breathing. When you give naloxone, it reverses the fentanyl and the person begins breathing again.

Xylazine causes a different kind of sedation through a non-opioid mechanism. It creates a deep, unconscious state that naloxone cannot touch. So when someone overdoses on fentanyl that contains xylazine, naloxone reverses the fentanyl component and may restore some breathing, but the person often remains deeply sedated and may not fully regain consciousness as quickly as expected.

This does not mean naloxone is useless in a tranq-fentanyl overdose. It still reverses the fentanyl and reduces respiratory suppression. But it means that even after successful naloxone administration, the person may remain unconscious for an extended period and require emergency medical care to monitor and support breathing.

“Naloxone will not reverse the xylazine component of an overdose, but it should still be administered because it reverses the opioid component and can restore breathing. Always call 911.” — CDC Overdose Response Strategy, 2023

The Wound Problem: Tranq Wounds Are Different

The most distinctive and devastating effect of xylazine use, beyond the overdose risk, is the severe skin wounds it causes. These wounds appear at injection sites but are not limited to injection sites. In some cases, necrotic wounds appear on parts of the body far from where the drug was injected, which suggests a systemic vascular effect rather than purely local tissue damage.

Xylazine causes blood vessels to constrict severely. This reduces blood flow to tissue, causing it to die. The resulting wounds are open, necrotic sores that can spread rapidly and become infected with bacteria including antibiotic-resistant strains. Left untreated, they can progress to the point of requiring amputation.

People who use tranq-fentanyl often continue using despite open wounds because the drug prevents them from feeling pain at the site. The damage accumulates without the normal pain signals that would prompt someone to seek care. By the time wounds come to medical attention, they are often deep and serious.

Signs of Xylazine Wounds

• Open sores that do not heal, particularly on the arms, legs, and ankles
• Dark, blackened, or gray tissue at wound edges indicating necrosis
• Wounds that appear far from injection sites
• Swelling and warmth around wounds indicating infection
• Rapidly expanding wound size

If someone you know has wounds like these, they need medical attention urgently. Many hospital emergency departments and harm reduction organizations are now trained to treat xylazine wounds specifically. Ask specifically about wound care services when contacting a provider.

How to Identify Xylazine in the Supply

Unlike fentanyl, there are no currently widely available consumer-grade test strips for xylazine. Some harm reduction organizations are beginning to distribute xylazine test strips, but they are not as available as fentanyl strips. A sample that tests positive for fentanyl should be assumed to potentially contain xylazine, particularly in regions where tranq is known to be present in the supply.

The DEA reported in 2023 that xylazine-fentanyl was detected in all 50 states. Prevalence varies significantly by region. The Northeast, particularly Philadelphia, has been heavily affected, but xylazine has spread to mid-Atlantic states, the South, and major West Coast cities.

What Families Can Do

Have Naloxone and Know Overdose Response

Because naloxone reverses the fentanyl in a tranq-fentanyl combination, it is still essential. Always administer naloxone in a suspected overdose, call 911, and be prepared to keep the person in the recovery position and monitor their breathing even after administering naloxone. They may not wake up as quickly as in a fentanyl-only overdose.

Watch for Skin Changes

If you have a loved one who injects drugs, gently ask about their skin. Wounds that are not healing, particularly dark-edged sores on limbs, warrant immediate medical evaluation. Many people are embarrassed to seek care for wounds. Encouragement from family can make the difference between keeping a limb and losing it.

Understand That Standard Detox Protocols May Need Adjustment

Xylazine itself can cause withdrawal symptoms including agitation and hypertension that are distinct from opioid withdrawal. There is no FDA-approved treatment for xylazine withdrawal. Clinicians are developing protocols for managing it, which often involve addressing both the opioid withdrawal component with buprenorphine or methadone and the xylazine-specific symptoms with medications that stabilize blood pressure and agitation.

If your loved one is seeking treatment and has been using tranq-fentanyl, tell the treatment program. The information helps them plan appropriate care.

Look for Harm Reduction Programs That Address Xylazine

Many harm reduction programs have updated their services in response to xylazine. This includes specialized wound care (sometimes called “wound care drop-ins”), distribution of wound dressings, naloxone with education specific to tranq overdoses, and services to help connect people to treatment.

• Next Distro (nextdistro.org): Distributes supplies by mail in many states
• SAMHSA Treatment Locator: Helps find local treatment and harm reduction programs
• National Alliance of State Pharmacy Associations: Lists pharmacies offering naloxone by state

Talking to a Loved One About Tranq

If your loved one is using illicit opioids, they may not know that what they are using contains xylazine. The name “fentanyl” is in the news constantly. Many people using the drug are unaware of adulterants like tranq or the specific risks they create.

A non-judgmental conversation focused on safety, not shame, is more likely to be heard. You might say: “I’ve been reading about something called xylazine that’s showing up in the drug supply and it causes wounds that can get really serious. I just want to make sure you know what to look for.” That is a conversation about information, not an ultimatum. It may open a door.

A Rapidly Changing Situation

The xylazine situation is evolving quickly. Researchers, public health officials, and harm reduction workers are learning new information about its effects, prevalence, and best practices for wound care and withdrawal management on an ongoing basis. What is true in 2024 may be updated by 2025 as more data becomes available.

What does not change is the basic response: naloxone, call 911, watch for wounds, and encourage treatment when the person is ready. These remain the most important things a family can do.

Why Addiction and Anxiety/Depression So Often Happen Together

If you have an addiction and also struggle with anxiety or depression, you are not unusual. You are actually in the majority. Co-occurring substance use disorders and mental health conditions, called dual diagnosis, are more the rule than the exception in people seeking addiction treatment. Roughly 50 percent of people with a substance use disorder also have at least one co-occurring mental health condition, according to SAMHSA data.

Understanding why addiction and anxiety or depression so often appear together changes how treatment should be approached. It also helps remove the confusion and shame that many people feel about “having so many problems.” These conditions are not separate failures. They share biological roots, reinforce each other, and in many cases are two expressions of the same underlying vulnerability.

How Common Is Dual Diagnosis?

• Approximately 9.5 million adults in the US have co-occurring substance use and mental health disorders
• People with anxiety disorders are 2 to 3 times more likely to have an alcohol use disorder
• Major depression doubles the risk of a substance use disorder
• Only about 9 percent of people with dual diagnosis receive treatment for both conditions
• Treating only one condition without the other significantly reduces the likelihood of sustained recovery

The Three Models of Why They Co-Occur

Researchers have proposed several explanations for why addiction and mental health disorders co-occur so frequently. Each applies in different cases, and often more than one is operating at the same time.

1. Self-Medication

The self-medication hypothesis proposes that people with untreated or under-treated anxiety or depression turn to substances because they provide temporary relief from symptoms. Alcohol reduces anxiety acutely because it enhances GABA (a calming neurotransmitter) and inhibits glutamate (an excitatory one). Cannabis can decrease the subjective experience of anxiety at low doses. Opioids can dull emotional pain as well as physical pain. Stimulants can temporarily relieve the energy deficit and executive dysfunction of depression.

The relief is real, and it works in the short term. The problem is that the brain adapts to the substance over time, requiring more to get the same effect, and the underlying psychiatric condition often worsens with sustained use, as the substance disrupts the very neurochemical systems that regulate mood and anxiety.

Self-medication is not a character flaw. It is a rational response to unmanaged symptoms. But the treatment is more specific and effective when the mental health condition is identified and treated directly, not just masked.

2. Substance-Induced Mental Health Disorders

Chronic heavy use of addictive substances can cause anxiety or depression as a direct physiological consequence. Alcohol-induced depression is a well-documented phenomenon: alcohol suppresses the central nervous system, and with chronic use, the neurochemical imbalances it creates produce depressive symptoms that can be as severe as major depressive disorder.

Stimulants like cocaine and methamphetamine, through their depletion of dopamine and serotonin with chronic use, can produce profound depression during cessation. Cannabis, particularly with heavy high-THC use, is associated with increased anxiety and, in some studies, elevated rates of panic disorder in long-term users.

In these cases, treating the substance use disorder is the primary intervention for the mental health symptoms. But the co-occurring symptoms still need to be monitored and addressed because the person may have a heightened vulnerability that continues after abstinence.

3. Shared Genetic and Neurobiological Vulnerability

The third model, which carries perhaps the strongest scientific support, is that addiction and mental health disorders share underlying genetic and neurobiological risk factors. Twin studies and genome-wide association studies have identified overlapping genetic variants that increase risk for both alcohol use disorder and major depression, and for both anxiety disorders and substance use disorders.

These shared roots operate through overlapping neurobiological systems, particularly the dopamine reward path, the hypothalamic-pituitary-adrenal (HPA) stress axis, and serotonin signaling. When these systems are dysregulated through genetics, trauma, early adversity, or epigenetic factors, they create vulnerability to both conditions.

“The high rate of co-occurrence between substance use disorders and psychiatric disorders is not coincidental. It reflects overlapping neural circuitry, shared genetic architecture, and the direct neurobiological effects of substances on mental health systems.” — NIDA, Comorbidity Report, 2021

Childhood Trauma as a Common Root

Adverse childhood experiences (ACEs) including abuse, neglect, parental substance use, and household instability are strongly associated with both mental health and substance use disorders in adulthood. The ACE study, one of the largest studies of its kind, found that each additional ACE score point dramatically increased the likelihood of both depression and heavy alcohol or drug use in adulthood.

Childhood trauma affects the development of the stress response system, alters hippocampal volume, and increases baseline cortisol levels. These changes increase both the vulnerability to mood and anxiety disorders and the rewarding properties of substances that temporarily reduce the heightened stress response.

Effective dual diagnosis treatment often needs to address the underlying trauma as part of the treatment plan, not just the presenting symptoms of anxiety, depression, and substance use.

Why Treating One Without the Other Does Not Work

Addiction treatment that ignores the co-occurring anxiety or depression sends the person back into the community with the same unmanaged symptoms that drove them to substances in the first place. Without treatment for the mental health condition, the pull toward self-medication remains strong, and relapse is highly probable.

Conversely, mental health treatment that ignores substance use fails for similar reasons. Antidepressants or anti-anxiety medications are significantly less effective when the person continues to use alcohol or other substances, which interfere with medication metabolism and continue to disrupt the neurochemical systems the medications are trying to stabilize.

Integrated treatment, meaning simultaneous treatment of both conditions by a coordinated team, produces better outcomes than sequential or parallel treatment. This is now considered the standard of care for dual diagnosis by SAMHSA, NIDA, and major addiction medicine organizations.

What Effective Dual Diagnosis Treatment Looks Like

Integrated Assessment

Diagnosis of the mental health condition should ideally be made after an adequate period of abstinence, because active substance use distorts all psychiatric symptom presentations. Symptoms assessed during active intoxication or acute withdrawal may not reflect the person’s true baseline. A careful clinical history that distinguishes substance-induced symptoms from pre-existing conditions guides treatment planning.

Evidence-Based Psychiatric Treatment

Depending on the specific mental health condition:

• Major depression: SSRIs, SNRIs, and evidence-based psychotherapy (particularly CBT and behavioral activation)
• Generalized anxiety disorder: SSRIs, SNRIs, buspirone, and CBT
• PTSD: Trauma-focused CBT, EMDR, prolonged exposure, and in some cases prazosin for nightmares
• Bipolar disorder: Mood stabilizers and careful monitoring, as stimulants and alcohol significantly worsen bipolar cycling

Substance Use Disorder Treatment

Integrated programs address both conditions simultaneously. Medication-assisted treatment for opioid or alcohol use disorder proceeds alongside psychiatric medication and therapy for the co-occurring condition. Therapists trained in both areas address the interplay between the conditions in session.

Peer Support and Community

Recovery communities that explicitly welcome and address dual diagnosis, such as Dual Recovery Anonymous and some SMART Recovery meetings, provide peer support from people who understand the complexity of the co-occurring experience.

Getting the Right Diagnosis and Care

If you have struggled with addiction and also experience anxiety or depression, it is worth seeking evaluation from a psychiatrist or addiction medicine physician who has dual diagnosis experience. Many primary care and addiction settings still treat only one condition. Finding a provider or program that addresses both is not always easy, but it significantly improves outcomes.

SAMHSA’s Treatment Locator (findtreatment.gov) allows you to filter for programs that specifically offer dual diagnosis services. The effort to find a program that treats the whole picture is worth it. You are not a difficult case. You are a person with two connected, treatable conditions who deserves treatment that understands both.

Xanax and Benzodiazepine Withdrawal Timeline

Benzodiazepine withdrawal is one of the most dangerous drug withdrawal processes. It can cause grand mal seizures and, in severe cases, can be fatal, which puts it in the same category as alcohol withdrawal in terms of medical risk. If you or someone you love takes Xanax, Valium, Klonopin, Ativan, or any other benzodiazepine regularly and wants to stop, understanding the withdrawal timeline and medical risks is not optional reading. It is necessary information for staying safe.

Benzodiazepine withdrawal symptoms, their intensity, and timeline vary significantly depending on which drug you use, how long you have been taking it, and your daily dose. Short-acting benzos like Xanax (alprazolam) produce faster-onset, more intense withdrawal than long-acting ones like Valium (diazepam). This guide covers the full timeline and what medical support actually looks like in practice.

Critical Information Before Reading Further

• Never stop benzodiazepines abruptly without medical guidance
• Withdrawal seizures can occur even in people who were taking prescribed therapeutic doses
• A supervised taper is the standard of care, not cold turkey
• Withdrawal can be life-threatening and should be treated as seriously as alcohol withdrawal
• Even after stopping, some symptoms can persist for months (PAWS)

Why Benzodiazepine Withdrawal Is Dangerous

Benzodiazepines work by enhancing the effect of GABA, the brain’s primary inhibitory neurotransmitter. They slow neurological activity. With regular use over weeks to months, the brain compensates by reducing its own GABA sensitivity and upregulating excitatory systems.

When benzodiazepines are removed suddenly, the brain’s excitatory systems have no counterbalance. The result is a state of neurological hyperexcitability that can produce seizures, severe anxiety, hallucinations, and cardiac instability. This is the same mechanism that makes alcohol withdrawal dangerous, since alcohol also works on the GABA system.

This danger applies not only to people who misuse benzos in high doses. It can affect people who have been taking a prescribed therapeutic dose for months or years. Duration of use matters at least as much as dose in determining withdrawal risk.

Xanax vs. Valium vs. Klonopin: Why the Drug Matters

The half-life of the benzodiazepine you have been taking significantly affects when withdrawal begins and how it progresses.

Short-Acting Benzodiazepines (Xanax, Ativan, Halcion)

Xanax (alprazolam) has a half-life of 6 to 12 hours. Withdrawal symptoms can begin as early as 6 to 12 hours after the last dose. The onset is rapid, symptoms peak within 1 to 4 days, and the acute phase typically resolves faster than long-acting benzo withdrawal, though it can be more intensely uncomfortable at peak.

Long-Acting Benzodiazepines (Valium, Klonopin, Librium)

Valium (diazepam) has a half-life of 20 to 100 hours, and its active metabolites can stay in the system for days. Withdrawal from Valium may not begin until 24 to 48 hours after the last dose. The onset is slower, but symptoms can persist for a longer period and the peak can be delayed by a week or more.

Klonopin (clonazepam) has a half-life of 20 to 50 hours. Withdrawal often begins 1 to 3 days after stopping and can be prolonged, with symptoms lasting weeks in some cases.

The Benzodiazepine Withdrawal Timeline

Short-Acting Benzos (Xanax, Ativan): Days 1 to 4

Hours 6 to 24: Early symptoms appear rapidly for short-acting benzos. Anxiety, agitation, and insomnia begin. Racing thoughts and muscle tension are common. Heart rate may increase.

Days 2 to 4: This is the peak danger window for short-acting benzo withdrawal. Seizure risk is highest. Symptoms include:

• Severe anxiety and panic attacks
• Tremors and muscle spasms
• Sweating and heart palpitations
• Nausea and vomiting
• Insomnia
• Heightened sensory sensitivity (light, sound, touch feel overwhelming)
• Derealization and depersonalization (feeling disconnected from reality or yourself)
• Seizures (in some patients)
• Psychosis or hallucinations (in severe cases)

“Benzodiazepine withdrawal syndrome can be indistinguishable in severity from delirium tremens. Both require the same medical seriousness.” — Journal of Clinical Psychiatry, 2015

Long-Acting Benzos (Valium, Klonopin): Days 3 to 14

Days 1 to 3: Because of the longer half-life, symptoms emerge more slowly. Mild anxiety and sleep disruption begin, which may be mistaken for ordinary anxiety or insomnia rather than withdrawal.

Days 4 to 10: The acute phase for long-acting benzos. Anxiety, insomnia, tremors, and physical discomfort intensify. Seizure risk persists throughout this window. The slower onset does not make withdrawal safer overall; seizures can occur over a broader window compared to short-acting benzos.

Week 2 and Beyond: Symptoms begin to ease gradually but often do not resolve abruptly. Anxiety, sleep problems, and cognitive difficulty may persist for weeks.

Post-Acute Withdrawal Syndrome in Benzodiazepine Cessation

Post-acute withdrawal syndrome (PAWS) is particularly well-documented in benzodiazepine withdrawal. Some patients, particularly those who were on benzos for years, experience protracted symptoms that can last months. These include:

• Persistent anxiety that does not respond to standard anti-anxiety strategies
• Tinnitus (ringing in the ears)
• Cognitive impairment, “brain fog,” and memory problems
• Paresthesias (burning, tingling, or crawling skin sensations)
• Sensitivity to light, sound, and touch
• Poor sleep quality
• Intermittent muscle spasms

Protracted benzo withdrawal is sometimes called “benzo belly” or benzo PAWS informally. These symptoms are real, they are physiological, and they gradually improve with sustained abstinence, though recovery can take six months to two or more years in some cases.

How Benzodiazepine Withdrawal Is Treated Safely

Supervised Taper

The standard medical approach to benzodiazepine withdrawal is a slow, supervised taper rather than abrupt cessation. A physician reduces the dose gradually over weeks or months, giving the brain time to recalibrate with each incremental reduction. The Ashton Manual, developed by British pharmacologist Dr. Heather Ashton, is a widely referenced protocol for benzodiazepine tapering, often using diazepam (Valium) as a substitute because of its long half-life and easy dose reduction in small increments.

A taper that is too fast is still dangerous. Many patients report that even a 5 to 10 percent dose reduction per month is the fastest rate they can tolerate without significant symptom resurgence. The right pace varies by individual.

Medical Detox

For people who are physically dependent on benzos and need to stop quickly, a medically supervised detox program provides round-the-clock monitoring and medication management. Anticonvulsant medications, supplemental benzodiazepines on a tapering schedule, and supportive care for sleep and anxiety can all be part of inpatient detox management.

What Does Not Work

Cold turkey benzodiazepine cessation is dangerous and should not be attempted. Over-the-counter supplements and natural remedies cannot prevent seizures. Alcohol as a substitute (both work on GABA) is a high-risk strategy that creates a new dependence while not adequately stabilizing the neurological state. If you are dependent on benzos, the safest path is through a medical provider, not around one.

Getting Help for Benzodiazepine Dependence

If you have been prescribed benzodiazepines and have concerns about dependence, the conversation to have is with the doctor who prescribed them. You can also see an addiction specialist. You are not obligated to suffer through withdrawal alone, and you should not attempt it without support.

For help finding treatment, SAMHSA’s National Helpline (1-800-662-4357) is free and confidential. The Benzo Buddies online community (benzobuddies.org) is a peer support resource with extensive information on tapering protocols, though any taper should be medically supervised.

Stopping benzos is possible. It takes time, patience, and often a longer taper than feels comfortable. But recovery from benzodiazepine dependence is real and complete for most people who do it with appropriate support.

What Is the “Fentanyl Fold”?

If you spend time looking at overdose data or following harm reduction conversations, you have probably seen the phrase “fentanyl fold.” It describes a specific, dangerous behavior pattern observed at overdose scenes and in user accounts: people who have overdosed on fentanyl are found bent forward at the waist, their upper body folded over their legs. The position itself is a visible sign of the drug’s rapid, overwhelming neurological effect.

But the fentanyl fold is more than just a body position. It tells us something important about how fentanyl behaves in the body differently from other opioids, what makes its overdoses so fast-moving, and why immediate administration of naloxone is critical in a way that was not true with earlier opioid crises.

What the Fentanyl Fold Tells Us

• Fentanyl acts far faster than heroin or prescription opioids
• Users can lose consciousness within seconds or minutes of use
• The “fold” position reflects sudden muscle rigidity and loss of postural control
• It is documented in overdose scenes where the person lost consciousness while still seated
• This is distinct from heroin overdoses, which typically have a slower progression

Why Fentanyl Works So Fast

Fentanyl is a synthetic opioid that crosses the blood-brain barrier exceptionally quickly due to its high fat solubility. It is 50 to 100 times more potent than morphine by weight. When someone injects or smokes illicit fentanyl, the drug reaches the brain in a matter of seconds. Blood vessel collapse or loss of consciousness can follow within 30 to 60 seconds in a significant overdose.

This speed is the central medical problem. With heroin, a person might nod off gradually over several minutes, giving bystanders time to notice and respond. With fentanyl, the progression from use to unconsciousness to respiratory failure can happen faster than a person realizes they are overdosing. There is no warning. There is no gradual nod. One moment they are awake, and the next they are not.

“Fentanyl overdose is qualitatively different from heroin overdose in its speed of onset. The window for intervention is dramatically shorter.” — Dr. Nora Volkow, Director, National Institute on Drug Abuse

Chest Wall Rigidity: The “Wooden Chest” Effect

The folded body position is related to a well-documented pharmacological effect of fentanyl and other potent synthetic opioids called muscle rigidity syndrome or “wooden chest syndrome.” In high doses, fentanyl can cause the chest wall muscles to stiffen severely, making it physically difficult to breathe and to perform chest compressions if CPR is needed.

Chest wall rigidity was documented as a complication in surgical settings where fentanyl is administered by anesthesiologists, who manage it with muscle relaxants. In an overdose setting outside of a hospital, there are no muscle relaxants available, making this a serious complication for bystanders and first responders trying to help.

Naloxone can reverse the opioid effect, including the rigidity, which is one more reason rapid naloxone administration is critical in any suspected fentanyl overdose.

The Contaminated Supply Problem

One reason the fentanyl fold has become so visible is because fentanyl is no longer a drug that only people who seek it out are using. The Drug Enforcement Administration has confirmed that illicit fentanyl is now present in counterfeit pills, in the cocaine supply, in the methamphetamine supply, and in nearly all illicit heroin. People who do not know they are taking fentanyl are overdosing from it.

This cross-contamination is central to the current overdose crisis. Someone who buys what they believe is a Xanax bar or a Percocet pill from an unverified source may receive a counterfeit pill containing a lethal dose of fentanyl. Because they have no tolerance for opioids, the effect is even more rapid and the overdose risk is even higher.

• In 2023, the DEA reported that 7 out of 10 seized fake pills contained lethal doses of fentanyl
• Fentanyl is now the leading cause of drug overdose deaths in the US, surpassing all other drugs
• Over 70,000 Americans died of synthetic opioid overdoses in 2023, the majority involving fentanyl

Carfentanil and Nitazenes: Fentanyl Analogs That Are Even More Potent

The illicit drug supply has also seen the emergence of fentanyl analogs that dwarf even fentanyl’s potency. Carfentanil, a veterinary tranquilizer, is estimated to be 100 times more potent than fentanyl and 10,000 times more potent than morphine. A dose small enough to be invisible to the naked eye can cause overdose.

More recently, nitazenes, a class of synthetic opioids originally developed in the 1950s but never used medically, have appeared in the drug supply and in overdose data. Some nitazenes are estimated to be several times more potent than fentanyl. Standard naloxone doses may not be sufficient to reverse them, requiring multiple doses or higher-concentration formulations.

What the Fentanyl Fold Means for Harm Reduction

Never Use Alone

The fastest-moving risk in fentanyl overdose is that no one is present to respond. If someone uses fentanyl alone and loses consciousness, there is no one to call 911, no one to administer naloxone, and no one to do rescue breathing. The Never Use Alone hotline (1-800-484-3731) allows people who are using alone to stay on the phone with an operator who can call emergency services if they stop responding.

Fentanyl Test Strips

Fentanyl test strips are small, inexpensive strips that can detect the presence of fentanyl in a drug sample. They are not perfect, but they can identify contamination in a sample before use. Many harm reduction organizations distribute them for free. As of 2024, most US states have legalized fentanyl test strips after years of prohibiting them as drug paraphernalia.

Naloxone Availability

Naloxone (sold under brand names Narcan and Kloxxado) is an opioid antagonist that can reverse a fentanyl overdose. As of 2023, naloxone nasal spray is available over the counter at most pharmacies in the US without a prescription. It should be in the home of anyone who uses opioids or lives with someone who does.

For fentanyl specifically, multiple doses of naloxone may be needed because fentanyl’s high receptor affinity can outlast a single dose. Always call 911 even after administering naloxone. The effect of naloxone wears off in 30 to 90 minutes, and if the fentanyl is still in the system, the person can re-enter overdose after the naloxone wears off.

What to Do If You See the Fentanyl Fold

If you find someone bent forward and unresponsive, or see the specific folded position at a scene:

1. Try to wake them by calling their name and rubbing firmly on their sternum
2. If unresponsive, call 911 immediately
3. Administer naloxone nasally or via injection if available
4. Put the person in the recovery position (on their side) to prevent aspiration
5. Begin rescue breathing if they are not breathing and you are trained to do so
6. Stay until emergency services arrive
7. Give the person a second dose of naloxone after 2 to 3 minutes if they have not responded to the first

Most states have Good Samaritan laws that provide legal protection to people who call 911 at an overdose scene. Do not leave someone alone out of fear of legal consequences. The legal protections exist specifically to prevent that hesitation from costing lives.

Understanding the Fentanyl Crisis

The fentanyl fold, as a term, has spread through harm reduction circles, media coverage, and public health reporting as a shorthand for the particular speed and severity of fentanyl overdose. It is a visual reminder that the current drug supply is not the same as it was ten or even five years ago.

The best tools available right now are naloxone, fentanyl test strips, and a commitment never to use alone. These are not solutions to addiction. But they keep people alive long enough for solutions to be possible.

What to Say During an Intervention

If someone in your life is struggling with addiction and you are considering an intervention, the words you choose matter. An intervention is not about confrontation, shaming, or forcing a decision. It is a structured conversation designed to help someone recognize the impact of their substance use and take a concrete step toward help. What you say, how you say it, and how you respond to what they say back will determine whether the conversation opens a door or closes one.

Interventions work best when they are planned carefully, delivered from a place of genuine care, and offer something specific and actionable rather than just expressions of worry. This guide covers what the research and practice show about effective intervention language and communication, and what tends to undermine results.

What an Effective Intervention Does

• It expresses love and concern without shame or labels
• It describes specific behaviors and their observed consequences
• It connects the person to ready, specific treatment options
• It sets clear, honest consequences that family members are prepared to follow through on
• It gives the person an opportunity to respond and be heard

Before You Say Anything: The Setup Matters

The setting, timing, and participants of an intervention affect its outcome before a single word is spoken. Effective interventions are typically held when the person is sober or as sober as possible. They involve people the person genuinely trusts and respects: close family members, a trusted friend, sometimes an employer or clergy member. They do not involve people the person has a current conflict with, as this shifts the conversation from support to accusation.

Prepare everyone in advance. Each participant should write out what they plan to say. Not a script to be read robotically, but a structure so they stay focused under emotional pressure. Surprises in the heat of an intervention moment often lead to off-message statements that derail the conversation.

What to Actually Say

Start with Love and Intention

Open with something that makes clear why you are there. The person needs to feel that they are being approached because people care about them, not because they are being judged or punished. An opening might sound like:

“We’re here because we love you and we’re scared. We want to talk about some things we’ve been witnessing, and we want to do it together because we don’t know what else to do.”

Simple, direct, and emotionally honest. Not an accusation. Not a diagnosis. An opening.

Use “I” Statements About Specific Behaviors

The most effective intervention statements describe what the speaker personally witnessed and how it made them feel. They do not diagnose, label, or characterize the person. They describe specific, observable events.

Effective: “Last month, when you didn’t show up to my daughter’s birthday, she asked me where you were. I didn’t know what to tell her. I was heartbroken and I was scared.”

Less effective: “You’re an alcoholic and you’re destroying your relationships.”

The first statement is about a specific moment that is difficult to dismiss. The second invites argument about the label and puts the person on the defensive immediately.

Additional examples of effective “I” statements:

• “I’ve watched you go from someone who loved hiking to someone who won’t leave the house, and I miss you.”
• “When I found out what happened at work, I was so afraid for you I could barely sleep.”
• “I’ve been lying to my kids about why we don’t visit as often, and I can’t keep doing that.”

“The most persuasive intervention statements describe consequences the person cares about, not the ones you think they should care about.” — Partnership to End Addiction, Family Resource Guide

Name What You Are Seeing Without Diagnosing

You do not need to use the word “addict” or “alcoholic.” Many people refuse help specifically because they refuse those labels, even when they clearly meet the clinical criteria. The behaviors and consequences do not require a label to be addressed.

You can say: “The way alcohol is affecting your life” or “the drinking” or “what’s been happening since the pills started.” These describe the reality without demanding they accept a specific identity.

Present a Specific, Ready Option

This is one of the most critical components of an effective intervention that many families miss. Expressing concern and then saying “we think you should get help” leaves the person with no clear path. The gap between “I should get help” and “I’m actually in treatment” is where most attempts fail.

Before the intervention, identify a specific program, have the admissions call scheduled, or have a bed reserved. Then present it directly: “We’ve already talked to a treatment center. They have a place ready for you. If you’re willing to go, we can take you today.”

Immediate, concrete options dramatically increase the chance of immediate action. The moment of openness created by an intervention is time-limited. Having a specific path available changes the conversion rate from thought to action significantly.

State Consequences Clearly and Only If You Mean Them

Each participant can state what they will no longer do if the person does not accept help. These consequences should be:

• Specific: Not “things will be different” but “I will not let you stay at my house anymore.”
• Real: Only say it if you are genuinely prepared to follow through. Empty consequences teach the person that your boundaries are not real.
• Not punishments: Frame them as personal decisions made to protect yourself and your family, not as revenge or manipulation.

Example: “I’ve been covering for you at work for two years. If you don’t get help, I can’t keep doing that. I’ll tell the truth about what’s been happening if I’m asked.”

What to Avoid Saying

• Labels and diagnoses: “You’re an addict” or “You’re a drunk” invites defensive argument rather than honest engagement
• Ultimatums you will not enforce: Every violated ultimatum reduces your credibility in future conversations
• Comparisons to other people: “Your brother manages to hold a job” or “Your mother never did this” are shame statements, not helpful observations
• Predictions about the future: “You’re going to end up dead” may be true but tends to produce shutdown rather than engagement
• All-or-nothing framing: “It’s either rehab or we’re done” closes options. “We’re asking you to get help” leaves more room for a response.

What to Do When They React Badly

Expect anger, denial, or tears. These are normal responses and are not automatically signs that the intervention has failed. Many people who eventually accept help after an intervention initially became angry, walked out, or said things they later regretted.

If the person becomes very angry: Do not escalate. Let the anger pass without argument. Remain calm. Someone who is yelling has not closed the door entirely; they are reacting to being seen.

If they walk out: Do not chase and plead. Let them go. The conversation will have registered even if they do not show it immediately. Follow up within 24 to 48 hours with a calm, brief message of care.

If they agree and then change their mind: Have the treatment option still available. Keep the window open. Remind them gently that the offer stands.

Working with a Professional Interventionist

For high-stakes situations involving severe addiction, prior failed attempts, or concerns about how the person will respond, a professional interventionist can be worth the investment. The ARISE model and other non-confrontational professional intervention approaches have better evidence than unassisted confrontational interventions.

Look for an interventionist certified by the Association of Intervention Specialists. Credentials matter; this is a field where anyone can call themselves an interventionist. A skilled professional manages the group dynamics, keeps the conversation on track, and handles unexpected responses more effectively than most families can on their own.

After the Intervention

Whether the person accepts help or not, take care of yourself and the group. A debrief conversation among participants, led by a therapist if possible, processes what happened and prepares the group for next steps. If the person accepted help, coordinate logistics immediately while the willingness is there. If they did not, regroup and consider next steps without giving up.

Change in addiction often comes in stages. A single intervention conversation rarely produces instant, permanent change. But it can shift the ground slightly toward change, and small shifts accumulate over time.

What Is PAWS (Post-Acute Withdrawal Syndrome)?

Most people know that quitting alcohol, opioids, or benzodiazepines comes with an uncomfortable withdrawal period. What many people do not know is that symptoms can continue long after the acute withdrawal window closes. Post-acute withdrawal syndrome, or PAWS, is a cluster of neurological and psychological symptoms that persist weeks, months, or even longer after a person stops using a substance. It is one of the primary drivers of relapse in the first year of recovery, and it is poorly understood by many people going through it.

Understanding PAWS matters because people who experience it often interpret the returning symptoms as evidence that they cannot get sober, that recovery is impossible for them, or that they are simply broken. In most cases, none of those things are true. What is true is that their brain is in a prolonged recovery process that is following a predictable, if frustrating, pattern.

What to Know About PAWS

• PAWS follows the acute withdrawal phase, typically appearing at 2 to 4 weeks after stopping
• Symptoms are primarily neurological and psychological rather than physical
• PAWS can last months to two years depending on the substance and duration of use
• Symptoms often fluctuate rather than being constant
• Stress, illness, and major life events can trigger PAWS episodes during the recovery period

What Causes Post-Acute Withdrawal Syndrome

PAWS is a consequence of the brain’s slow recovery from the neurochemical changes caused by sustained drug or alcohol use. Heavy, long-term use of addictive substances alters the structure and function of multiple neurotransmitter systems: dopamine, serotonin, GABA, glutamate, and the endogenous opioid system, among others.

These systems cannot recalibrate overnight. The brain is neuroplastic, meaning it changes in response to experience, but that change happens gradually. The acute withdrawal phase reflects the most dramatic phase of recalibration. PAWS reflects the slower, ongoing process of the brain recovering its baseline function.

Neuroimaging research has shown measurable differences in brain structure and function in people in early recovery, including reduced gray matter density in prefrontal regions and altered activity in reward circuits. These changes gradually reverse with sustained abstinence, but the timeline extends well past the acute withdrawal period.

Which Substances Cause PAWS

PAWS is documented across multiple substance categories, but it is most well-characterized after:

• Alcohol: PAWS after alcohol use disorder can last 6 to 24 months
• Opioids (including fentanyl, heroin, prescription opioids): typically peaks in early weeks, can persist 6 months or more
• Benzodiazepines: Protracted benzo withdrawal is well-documented, with some patients reporting symptoms lasting 1 to 2 years or longer
• Stimulants (cocaine, methamphetamine): primary feature is anhedonia and mood dysregulation lasting months
• Cannabis: PAWS symptoms including sleep disruption and mood changes typically resolve within 1 to 3 months

Common PAWS Symptoms

Post-acute withdrawal symptoms vary by substance but share a common core of neurological and psychological features:

Mood and Emotional Symptoms

• Depression: Often described as a gray, flat feeling rather than acute sadness. The brain’s reward system is still recovering its sensitivity to natural pleasures.
• Anxiety: Persistent background anxiety or episodic panic that does not follow identifiable triggers
• Irritability: Disproportionate emotional reactions to minor frustrations
• Mood swings: Emotional instability without clear external cause
• Anhedonia: Difficulty feeling pleasure from activities that were previously enjoyable. This is the brain’s dopamine system still recalibrating.

Cognitive Symptoms

• Brain fog: Difficulty with clear thinking, processing speed, and decision-making
• Memory difficulties: Trouble retaining new information or recalling recent events
• Poor concentration: Difficulty sustaining attention, particularly on complex tasks
• Executive function problems: Difficulty with planning, organization, and following through on commitments

Physical Symptoms

• Sleep disruption: Difficulty falling or staying asleep, vivid or disturbing dreams, non-restorative sleep
• Fatigue: Persistent low energy that is disproportionate to activity level
• Variable appetite: Appetite that fluctuates without clear relationship to stress or activity
• Sensitivity to stress: Physical and psychological stress responses that feel larger than the situation warrants

Addictive Behavior Symptoms

• Cravings that resurface during stressful periods or in response to specific triggers (people, places, emotions)
• Impulsive behavior: Difficulty resisting urges that would previously have been easily managed
• Obsessive thinking about the substance, about using, or about the past

“Post-acute withdrawal is not a sign of failure. It is a sign that the brain is healing on its own timeline, which does not always match the timeline we wish it would.” — American Society of Addiction Medicine White Paper on Chronic Disease Management

PAWS Is Not Linear

One of the most disorienting things about post-acute withdrawal syndrome is that it does not get steadily better over time in a predictable way. Instead, it tends to come and go in waves. Periods of relative stability are interrupted by periods of intensified symptoms, often triggered by stress, illness, major life changes, or even positive events that disrupt routine.

When a PAWS episode hits after a period of feeling well, it can feel like a relapse has already happened or that recovery is going backwards. It has not. The episodic nature of PAWS is expected and documented. The episodes decrease in frequency and intensity over time, even when that is not obvious in the moment.

Understanding this in advance is one of the most protective things you can do. When an episode hits, having a framework for it (“this is PAWS, it will pass, this is not permanent”) activates the prefrontal cortex’s ability to manage the experience rather than allowing the emotional distress to escalate unchecked.

What Helps With PAWS

Time and Abstinence

The primary treatment for PAWS is time and continued abstinence. The brain recovers with sustained abstinence. Using again resets the clock and typically produces a more severe course of PAWS in subsequent abstinence attempts.

Regular Exercise

Exercise is the most consistently documented non-pharmacological intervention for PAWS. It produces endocannabinoid and endorphin release, upregulates neuroplasticity factors, reduces cortisol, and improves sleep quality. Even moderate exercise, such as 30-minute walks 5 days per week, has measurable effects on mood and cognitive function in early recovery.

Sleep Prioritization

Sleep is when the brain consolidates learning, processes emotions, and performs neurological maintenance. During PAWS, sleep is often disrupted, which amplifies every other symptom. Consistent sleep timing, a dark and quiet sleep environment, and limiting caffeine after noon improve sleep quality during recovery.

Stress Management

Because stress is a primary PAWS trigger, developing genuine stress management skills rather than coping strategies that were previously (and inadequately) filled by the substance is central to managing PAWS. Mindfulness-based approaches, cognitive behavioral techniques, and regular physical activity all have evidence for stress modulation in recovery populations.

Therapy and Peer Support

Cognitive behavioral therapy helps identify the thought patterns that amplify PAWS episodes and replace them with more accurate interpretations. Peer support groups provide community that normalizes the experience (“everyone in recovery deals with this”) and reduces the isolation that makes PAWS episodes worse.

Medical Management

Some PAWS symptoms are severe enough to warrant medical treatment. Persistent depression may respond to antidepressants. Sleep aids can help during the worst periods. Anxiety disorders that were previously masked by substance use may need their own treatment. A physician or psychiatrist familiar with addiction medicine can assess which symptoms need pharmacological support versus those that will resolve with time.

PAWS Is Temporary

Post-acute withdrawal syndrome is one of the most important things to understand about recovery because it is responsible for so much preventable relapse. The person who relapses because they have been “feeling fine” for three months and suddenly feels terrible is often experiencing a PAWS episode, not an indication that sobriety isn’t working.

PAWS ends. For most people, it becomes progressively less frequent and less intense over the first year and beyond. The brain does recover. The recovery is not always visible from inside the process, but the research measuring neurological recovery in sustained abstinence is consistent and encouraging. Keep going.

What Does Rehab Cost Without Insurance?

If you or someone you love needs addiction treatment and you do not have insurance, the question of what rehab costs can feel like a barrier before you even start looking. The honest answer is that rehab costs vary enormously: from completely free through state-funded programs to $100,000 or more for high-end residential care. Knowing where the costs come from and what your options are can turn an overwhelming search into a manageable one.

The rehab cost without insurance depends on several key factors: the type of program (detox, inpatient, outpatient), the duration of treatment, the geographic location, and the amenities offered. This guide breaks those factors down with realistic current figures and helps you identify affordable pathways, even without private insurance.

Cost Ranges at a Glance

• State-funded or free rehab: $0, income-based eligibility
• Medical detox without insurance: $500 to $1,500 per day, 5 to 10 days
• Short-term inpatient (30 days): $5,000 to $80,000 depending on level of amenity
• Long-term residential (90 days): $12,000 to $100,000+
• Partial hospitalization (PHP): $350 to $500 per day
• Intensive outpatient (IOP): $1,500 to $5,000 for the full program
• Standard outpatient: $100 to $500 per session

Why Rehab Costs Vary So Much

The staggering range in rehab pricing comes from several factors that are unrelated to treatment quality:

Staffing Ratios and Credentials

Programs with high staff-to-patient ratios and credentialed clinicians, including psychiatrists, licensed therapists, nurses, and addiction medicine physicians, cost more to operate than programs with lower staffing. Higher credentials do not always mean better outcomes, but adequate staffing is a meaningful quality indicator.

Location

A 30-day program in rural Kansas costs a fraction of the same program in California, Florida, or New York. Programs in high-cost-of-living areas pass those costs on to patients. Traveling for treatment is common for exactly this reason: some people can access better care at lower cost by going out of state.

Amenities

Executive and luxury rehabs can charge $10,000 to $30,000 per month or more, in part because of amenities: private rooms, chef-prepared meals, yoga and equine therapy, fitness centers, and resort-like settings. The amenities themselves do not improve outcomes compared to standard evidence-based care. They serve comfort and privacy, which matters to some people, but it is important not to confuse luxury with clinical effectiveness.

Program Type

The level of care directly drives cost. 24-hour care with medical staffing costs more than outpatient sessions three times a week. This is expected and appropriate. The question is not which is cheapest but which is clinically appropriate.

Medical Detox Cost Without Insurance

Medical detox typically costs $500 to $1,500 per day in a standalone detox facility or hospital setting. A 5 to 7-day alcohol detox without insurance might cost $3,500 to $10,500. A longer detox for benzodiazepine withdrawal (which requires a gradual taper) could run significantly higher.

Hospital-based detox for a complicated withdrawal, such as delirium tremens or seizures, can cost far more, particularly in a hospital setting where ICU care may be involved. Medical necessity billing in a hospital is a separate track from scheduled detox, and those costs can be in the tens of thousands of dollars for multi-day ICU stays.

Residential Rehab Cost Without Insurance

Standard 30-Day Programs

Standard 30-day residential programs without the luxury add-ons typically cost $5,000 to $15,000. These programs provide housing, meals, individual and group therapy, medical oversight during early recovery, and a structured daily schedule. This is the middle tier of the market: not free, not resort-level, but clinically sound.

Luxury and Executive Programs

High-end residential programs may charge $30,000 to $80,000 for 30 days or more. These often cater to high-profile clients who need privacy, CEOs who cannot be away from business entirely, or people who simply prefer a premium environment. The clinical programming is often equivalent to standard programs. The premium is for the setting and the confidentiality infrastructure.

Therapeutic Communities (6 to 12 months)

Long-term therapeutic communities often operate on sliding scale fees or are state-funded. When private pay is required, costs are significantly lower per day than short-stay residential (because overhead is different), but total cost for 6 to 12 months can still add up to $15,000 to $50,000.

Outpatient Rehab Cost Without Insurance

Outpatient treatment is significantly less expensive than inpatient because you are not paying for housing or 24-hour staffing.

• PHP (partial hospitalization): $350 to $500 per day, usually 20 to 30 days = $7,000 to $15,000 total
• IOP (intensive outpatient): $1,500 to $5,000 for a standard 8 to 12-week program
• Standard outpatient therapy: $100 to $300 per session without insurance, often weekly
• Medication-assisted treatment with buprenorphine: $150 to $500 per month for medication plus office visits

“The societal return on investment for addiction treatment is estimated at $4 to $7 saved for every $1 spent, primarily through reduced criminal justice costs and increased economic productivity.” — NIDA, 2020

Finding Affordable Rehab Without Insurance

State-Funded and SAMHSA-Funded Programs

Every state has a substance abuse agency that funds treatment for residents who cannot afford private care. These programs are free or income-based sliding scale. Waitlists can be a challenge, particularly in rural areas, but many states have prioritized rapid access to treatment following federal legislative pressure. The SAMHSA Treatment Locator at findtreatment.gov allows you to filter for free and sliding-scale programs by zip code.

Federally Qualified Health Centers (FQHCs)

FQHCs are federally funded community health centers that provide services including substance use treatment on a sliding scale based on income. Many have reduced-cost medication-assisted treatment programs. You can find your nearest FQHC at findahealthcenter.hrsa.gov.

Nonprofit and Faith-Based Programs

Nonprofit rehabs, including programs run by the Salvation Army, Catholic Charities, and other faith-based organizations, provide free or very low-cost residential treatment. The clinical model varies by organization. Some use 12-step based approaches; others use evidence-based clinical models. These programs are worth contacting directly about availability and structure.

Medicaid

If you do not have insurance but your income is below your state’s Medicaid threshold, you may qualify for Medicaid, which covers addiction treatment including detox, residential, and outpatient care in participating states. The ACA Medicaid expansion has significantly broadened eligibility in most states. You can apply through healthcare.gov or your state’s Medicaid portal.

Payment Plans and Financing

Many private rehab centers offer in-house payment plans or work with third-party medical financing companies like CareCredit or Prosper Healthcare Lending. These allow you to spread the cost over months or years. Interest rates vary, so read the terms carefully before committing.

Scholarships and Grants

Some treatment centers have scholarship funds for patients who cannot afford the full cost. This is not publicized broadly but is worth asking about directly when contacting treatment centers. Some nonprofit organizations also offer direct grants for treatment, including the Partnership to End Addiction, which has a family helpline that can connect people to financial assistance resources.

Cost Is Not a Reason to Delay

The financial barrier to treatment is real, but there are more options than most people realize. Free and low-cost treatment exists in every state. Medicaid covers treatment for those who qualify. Outpatient treatment, which can be effective for the right person, costs a fraction of residential care.

Call SAMHSA’s National Helpline (1-800-662-4357) for a confidential conversation about cost and options in your area. The call is free, available 24 hours a day, and staff can help you identify state-funded options, sliding-scale programs, and Medicaid-eligible providers even if you do not know where to start.

What Is Delirium Tremens (DTs)?

Delirium tremens, often called DTs, is the most severe form of alcohol withdrawal. It is a medical emergency that can be fatal without immediate treatment. Despite how serious it is, many people do not know the warning signs until a crisis is already unfolding.

Delirium tremens typically develops 48 to 96 hours after a person’s last drink. It is not something that happens to everyone who stops drinking. But for those who have been drinking heavily for years and stop abruptly, the risk is real and should be taken seriously. Understanding DTs can help you recognize the signs early and get the right medical help before the situation becomes life-threatening.

What Happens in the Body During DTs

• DTs affect roughly 3 to 5 percent of people going through alcohol withdrawal
• Without treatment, the mortality rate is estimated at 5 to 15 percent
• With proper medical care, most people survive and recover fully
• Symptoms peak between 48 and 72 hours after the last drink
• Risk factors include prior DT episodes, long-term heavy drinking, and older age

What Delirium Tremens Feels Like

Delirium tremens is not just a bad hangover or strong withdrawal. It is a full neurological crisis. The brain, which has been chemically altered by years of heavy alcohol use, loses its ability to regulate itself when alcohol is suddenly removed.

The most defining feature of DTs is delirium: a sudden state of profound confusion, disorientation, and inability to think clearly. This is distinct from the anxiety and shakiness of milder withdrawal. A person in delirium may not know where they are, who you are, or what year it is.

Core Symptoms of Delirium Tremens

• Severe confusion and disorientation that comes on rapidly
• Hallucinations that may be visual (seeing insects, animals, or people), auditory (hearing voices or sounds), or tactile (feeling something crawling on skin)
• Extreme agitation and restlessness
• Fever, often above 100.4°F (38°C)
• Rapid heart rate and elevated blood pressure
• Profuse sweating
• Tremors affecting the hands, arms, and potentially the whole body
• Seizures, which may precede or accompany delirium

Not everyone with DTs will experience all of these symptoms, but any combination of sudden confusion plus elevated heart rate plus fever is a strong signal that emergency care is needed.

Who Is at Risk for Delirium Tremens?

DTs do not occur randomly. There are clear risk factors that identify who is most vulnerable.

History of Prior DTs or Withdrawal Seizures

If you have experienced DTs or a seizure during a previous withdrawal attempt, your risk for DTs in a future withdrawal is significantly elevated. The brain becomes sensitized with each withdrawal episode, a process called kindling. Each subsequent detox can be more severe than the last, even with the same drinking pattern.

Amount and Duration of Drinking

People who have been drinking very large amounts daily for years are at higher risk. A study published in Alcohol and Alcoholism found that the number of prior detox episodes and the quantity of daily alcohol consumed were the strongest predictors of DT risk.

Older Age and Poor Physical Health

Older adults and people with liver disease, malnutrition, or concurrent infections are more likely to develop DTs and have more severe courses. The liver’s reduced capacity to process alcohol and the body’s diminished resilience both contribute to increased severity.

Abrupt Cessation After Prolonged Use

People who stop drinking cold turkey after long periods of daily heavy use are at higher risk than those who taper gradually or who stop after a shorter drinking period. If you have been drinking a fifth of liquor or more per day for months, stopping without medical supervision is genuinely dangerous.

“Identifying patients at risk for alcohol withdrawal syndrome prior to hospitalization is critical, since early recognition and treatment significantly reduces morbidity and mortality.” — New England Journal of Medicine, 2014

How Delirium Tremens Is Diagnosed

There is no single blood test that diagnoses DTs. Clinicians use a combination of patient history, physical examination, and symptom assessment tools. The most commonly used tool is the Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised (CIWA-Ar), which scores 10 different withdrawal symptoms to gauge severity.

A score above 15 on the CIWA-Ar typically indicates severe withdrawal and a need for close monitoring. Scores above 20 are associated with significantly higher DT risk.

Doctors will also run lab work to check for electrolyte imbalances, liver function, and blood count, all of which can affect the course of withdrawal and treatment response.

How Delirium Tremens Is Treated

DTs require immediate hospitalization. There are no safe at-home remedies. Treatment typically takes place in an intensive care unit or a step-down monitored unit where vital signs can be tracked continuously.

Benzodiazepines

The first-line treatment for DTs is benzodiazepines. Drugs like diazepam (Valium), lorazepam (Ativan), or chlordiazepoxide (Librium) calm the overactivated central nervous system, prevent further seizures, and reduce the risk of death. Dosing is adjusted based on symptom severity, often using a protocol-driven approach tied to CIWA-Ar scores.

Phenobarbital

For severe or refractory DTs that do not respond adequately to benzodiazepines, phenobarbital is an effective alternative or add-on. Some treatment centers use phenobarbital as a first-line agent because of its long half-life and predictable dosing.

Thiamine and Nutritional Support

Heavy alcohol use depletes thiamine (vitamin B1). Without adequate thiamine, Wernicke’s encephalopathy, a serious neurological complication, can develop. All patients suspected of DTs receive intravenous thiamine before glucose is administered. Electrolyte replacement and IV fluids support hydration and correct imbalances caused by vomiting and fever.

Antipsychotics (When Needed)

When hallucinations or agitation are severe, antipsychotic medications like haloperidol may be used alongside benzodiazepines to control symptoms. They are not used as stand-alone treatment for DTs but can help manage specific symptoms.

How Long Do Delirium Tremens Last?

DTs typically resolve within 3 to 5 days with appropriate treatment. The acute crisis usually peaks at around 72 hours. After the worst passes, most people are left with fatigue, cognitive cloudiness, and emotional fragility. Physical recovery from severe DTs can take one to two weeks in a hospital setting.

Some people experience lingering anxiety, sleep problems, and mood disturbances for weeks after DTs resolve. This overlaps with post-acute withdrawal syndrome and may need ongoing medical and psychological support.

When to Call 911

Call 911 immediately if someone who has recently stopped drinking shows any of these signs:

• Sudden severe confusion or inability to recognize familiar people
• Hallucinations
• Seizures
• High fever with agitation
• Loss of consciousness

Do not try to manage DTs at home. Do not assume the person will sleep it off. DTs can progress from uncomfortable to fatal within hours.

Preventing Delirium Tremens

The most reliable way to prevent DTs is to undergo alcohol withdrawal under medical supervision. Medically managed detox uses medications to keep the central nervous system from becoming dangerously hyperexcitable. A supervised detox can prevent seizures, stop DTs from developing, and make withdrawal significantly safer and more manageable.

If you or someone you know drinks heavily and wants to stop, talk to a doctor first. A simple conversation can prevent a life-threatening emergency. You can also call SAMHSA’s helpline at 1-800-662-4357 to find local detox services, many of which offer same-day admission.

What Does Fentanyl Withdrawal Feel Like?

Fentanyl withdrawal is one of the most physically demanding drug withdrawal experiences. People who have gone through it often describe it as an extreme version of opioid withdrawal: faster to start, more intense at its peak, and disorienting in ways that can make it feel insurmountable without medical support.

Because fentanyl is 50 to 100 times more potent than morphine and has a very short half-life, the body reacts quickly when it is gone. Fentanyl withdrawal can begin within hours of the last dose for short-acting formulations. Understanding what to expect, and more importantly, what treatment options exist, can make the difference between attempting withdrawal alone and getting care that actually works.

Key Facts About Fentanyl Withdrawal

• Symptoms can begin 8 to 24 hours after the last dose of illicit fentanyl
• Peak symptoms typically occur between 36 and 72 hours
• Acute withdrawal usually resolves within 5 to 10 days
• Fentanyl is now present in the majority of illicit opioid supplies in the US
• Medications like buprenorphine significantly reduce withdrawal severity and prevent relapse

Why Fentanyl Withdrawal Is Different

Most opioid withdrawal information is based on heroin or prescription painkillers like oxycodone. Fentanyl behaves differently because of its potency and pharmacokinetics. It binds very tightly to opioid receptors, and when those receptors are suddenly unoccupied, the rebound effect is often more severe than with longer-acting opioids like methadone.

Another complication is fentanyl’s tendency to accumulate in fatty tissue. With regular use, fentanyl stores in body fat and releases slowly over time, which can extend withdrawal or cause symptoms to fluctuate unpredictably. This is different from heroin, which clears the body more uniformly.

What Fentanyl Withdrawal Feels Like: A Symptom-by-Symptom Account

Physical Symptoms

The physical experience of fentanyl withdrawal is relentless in its early stages. Most people describe a combination of:

• Muscle aches and cramps that feel like severe flu body aches, often in the back, legs, and abdomen
• Restless leg syndrome, an overwhelming urge to move the legs that makes sleep nearly impossible
• Sweating and chills alternating rapidly, sometimes simultaneously
• Goosebumps on the skin (this is the origin of the phrase “cold turkey”)
• Nausea and vomiting, sometimes severe enough to prevent oral medication
• Diarrhea, which can lead to dehydration if not managed
• Dilated pupils and sensitivity to light
• Yawning and watery eyes that intensify during peak withdrawal
• Elevated heart rate and blood pressure

“The most common description from patients going through fentanyl withdrawal is that it feels like their bones are being crushed and their skin is crawling at the same time.” — Clinician note, SAMHSA opioid treatment training

Psychological Symptoms

The mental and emotional aspects of fentanyl withdrawal are often what overwhelm people’s ability to stay in detox without support.

• Severe anxiety and panic, often described as dread with no specific object
• Profound irritability and agitation
• Insomnia, sometimes total inability to sleep for days
• Depression and emotional numbness
• Intense drug cravings that are triggered by discomfort and intensify during peak withdrawal
• Difficulty concentrating and making decisions

The psychological symptoms are why fentanyl withdrawal is so tightly linked to relapse. The discomfort becomes unbearable, and one dose relieves it immediately. That immediate relief is a powerful reinforcer that bypasses rational decision-making.

The Fentanyl Withdrawal Timeline

Hours 8 to 24: Onset

For illicit fentanyl, which is typically short-acting, the onset of withdrawal symptoms can begin as early as 8 hours after the last use. Early symptoms include yawning, watery eyes, anxiety, restlessness, and early muscle aches. You may feel increasingly uncomfortable but the worst has not arrived yet.

Hours 24 to 72: Peak Intensity

This is the hardest window. Symptoms build rapidly. Muscle cramps and abdominal pain intensify. Restless legs make sleep impossible. Sweating, chills, and nausea cycle continuously. Vomiting and diarrhea may occur simultaneously. Anxiety can reach panic-level intensity. The craving to use fentanyl to stop the suffering is strongest during this window.

Days 4 to 10: Gradual Improvement

The acute physical symptoms begin to ease by days 4 to 5 for most people. Muscle aches reduce in intensity. Appetite begins to return. Sleep, though still disrupted, becomes possible. By day 7 to 10, most of the acute physical symptoms have resolved.

Weeks to Months: Post-Acute Withdrawal

Many people experience persistent symptoms after the acute phase ends. These include difficulty sleeping, mood disturbances, low energy, anhedonia (inability to feel pleasure), and cravings that resurface during stressful periods. This post-acute phase can last weeks to months and is a primary driver of late-stage relapse.

Why Withdrawing Without Medical Help Is Dangerous

Fentanyl withdrawal itself is rarely fatal in otherwise healthy individuals. The danger comes from the circumstances around withdrawal. Severe dehydration from vomiting and diarrhea can cause electrolyte imbalances that require IV fluids. Aspiration of vomit while unconscious poses a risk. And most critically, if someone stops using fentanyl, loses their tolerance during withdrawal, and then relapses with their previous dose, they face a very high overdose risk.

This is why fentanyl overdose rates are elevated in the weeks immediately after a period of abstinence, including after a stay in jail, a hospitalization, or a solo withdrawal attempt. The body’s tolerance drops rapidly; a dose that previously felt normal can be lethal.

What Treatment Actually Helps

Buprenorphine (Suboxone)

Buprenorphine is the most evidence-based medication for managing fentanyl withdrawal and preventing relapse. It is a partial opioid agonist that activates opioid receptors enough to eliminate withdrawal symptoms and cravings without producing the high of full agonists. When combined with naloxone (as in Suboxone), it also deters misuse.

For fentanyl specifically, standard buprenorphine induction (starting when in mild withdrawal) works well. Research has largely resolved earlier concerns about precipitated withdrawal when buprenorphine is used appropriately. Low-dose induction protocols are increasingly used for patients coming off fentanyl specifically.

Methadone

Methadone is a long-acting full opioid agonist dispensed through federally regulated opioid treatment programs. It eliminates withdrawal symptoms and reduces cravings. For people with severe opioid use disorder or those who have struggled to maintain buprenorphine adherence, methadone can be more appropriate.

Comfort Medications

For people who decline medication-assisted treatment, comfort medications can reduce specific withdrawal symptoms:

• Clonidine for anxiety and elevated blood pressure
• Loperamide for diarrhea
• Ondansetron for nausea
• NSAIDs for muscle pain
• Gabapentin for restless legs and anxiety

Comfort medications reduce suffering but do not address cravings or prevent relapse the way buprenorphine and methadone do. They are better used as a bridge than a standalone approach.

Getting Through Fentanyl Withdrawal

Fentanyl withdrawal is survivable. It is painful, it is disorienting, and without support it is very hard to get through alone. The good news is that medications exist that can make withdrawal manageable and dramatically reduce the likelihood of relapse.

If you or someone you know is using fentanyl and wants to stop, contact a doctor, an opioid treatment program, or an emergency room. Buprenorphine can be started within hours of your last dose. You do not have to wait until you hit rock bottom to get help. The treatment works best when it starts early.

Weed Withdrawal vs. Anxiety: What’s Actually Happening?

When you stop using cannabis and anxiety surges, a basic question becomes hard to answer: is this withdrawal, or is this just who you are? For people who started using weed to manage anxiety in the first place, stopping often brings a rush of fear, dread, and nervous energy that feels overwhelming. Figuring out whether that anxiety is a temporary withdrawal symptom or a pre-existing condition that needs its own treatment changes everything about how you approach getting better.

Weed withdrawal and anxiety disorder overlap in most of their surface symptoms. Both can cause racing thoughts, restlessness, irritability, sleep disruption, and difficulty concentrating. The differences are in the timing, the triggers, the trajectory, and what actually helps each condition. This guide explains how to distinguish between the two and what to do in either case.

The Overlap Problem

• Anxiety is the most commonly reported symptom of cannabis withdrawal
• Many people who use cannabis heavily report having started to manage anxiety
• Withdrawal anxiety typically peaks within 3 to 6 days and improves within 2 weeks
• Anxiety disorder does not follow a clear declining trajectory tied to time since last use
• Accurate diagnosis of anxiety disorder is best done 4 to 6 weeks after stopping cannabis

Cannabis and Anxiety: The Complicated Relationship

Cannabis has a paradoxical relationship with anxiety. At low doses and in some individuals, it reduces anxiety. At higher doses, in regular users, and in people genetically predisposed to anxiety disorders, it can actually worsen anxiety over time.

Research shows that regular heavy cannabis use is associated with higher rates of anxiety disorders over the long term, not lower rates. The cannabinoid receptors that THC stimulates are distributed throughout the amygdala and prefrontal cortex, brain regions central to fear response and emotional regulation. Chronic stimulation of these receptors alters their functioning in ways that can increase baseline anxiety, particularly in the absence of cannabis.

This means that cannabis can feel like it is solving an anxiety problem while actually maintaining or worsening it. When you stop, the anxiety that was there all along, possibly amplified by the cannabis use itself, becomes measurable and felt.

“People who use cannabis to self-medicate anxiety often find their anxiety is worse after stopping than before they started. The cannabis provided short-term relief while the underlying disorder continued to develop.” — Harvard Review of Psychiatry, 2021

What Withdrawal Anxiety Looks Like

Cannabis withdrawal anxiety has a predictable pattern. It begins within 24 to 72 hours of stopping, intensifies over the first 3 to 6 days, and then gradually decreases. Most people notice significant improvement by week two. By week three, the anxiety is often at or below baseline.

Other features of withdrawal anxiety include:

• It is continuous rather than episodic, a persistent hum of unease rather than attacks
• It improves with time without treatment
• It is accompanied by other withdrawal symptoms like irritability, insomnia, and appetite loss
• It does not appear in specific situations; it is present most of the day
• It often feels unfamiliar, different from how you normally experience anxiety

What Anxiety Disorder Looks Like

Anxiety disorder, whether that is generalized anxiety disorder, social anxiety, panic disorder, or another form, has a different character and trajectory.

Generalized Anxiety Disorder (GAD)

GAD is characterized by persistent, excessive worry about multiple areas of life (work, health, relationships, finances) that the person finds difficult to control. It is present most days and has been present for at least six months. GAD does not resolve on its own without treatment or lasting behavioral change.

Panic Disorder

Panic disorder involves recurrent unexpected panic attacks, episodes of intense physical fear including heart pounding, shortness of breath, dizziness, and fear of dying, followed by persistent concern about having another attack. Cannabis can suppress panic attacks in some people, and stopping cannabis can unmask them.

Social Anxiety Disorder

Social anxiety disorder is a fear of social situations that is specific to being observed or judged by others. Many people use cannabis before social events because it temporarily reduces this specific fear. Stopping cannabis does not cause social anxiety disorder, but it can make a previously masked condition more apparent.

How to Tell Which One You Are Dealing With

In the first two weeks after stopping cannabis, it is genuinely difficult to distinguish withdrawal anxiety from an underlying anxiety disorder. Both are happening, and they overlap completely in their presentation.

The most reliable approach is to wait. Assess how you feel at four to six weeks after stopping. By that point, withdrawal is resolved for most people. The anxiety you feel at four to six weeks is a much more accurate picture of your baseline than anything you experience in the first two weeks.

Ask yourself:

• Is the anxiety decreasing over time, or is it staying the same or getting worse?
• Was I anxious before I started using cannabis, or did anxiety appear later?
• Were there specific situations, people, or topics that triggered anxiety before cannabis use?
• Did I start using cannabis specifically because it made me feel less anxious?

Answering yes to the last two questions suggests there was a pre-existing anxiety pattern. That does not mean you have an anxiety disorder, but it does suggest that stopping cannabis alone may not be enough to resolve your anxiety.

What Helps Withdrawal Anxiety

During the withdrawal period, the most effective strategies for managing anxiety are behavioral rather than pharmacological.

Exercise

Physical exercise reduces anxiety through multiple mechanisms: it increases endocannabinoid levels naturally, reduces cortisol, and produces endorphins. A consistent exercise routine during cannabis withdrawal has measurable effects on both the anxiety and the mood symptoms of withdrawal.

Controlled Breathing

Slow, diaphragmatic breathing activates the parasympathetic nervous system and physically reduces the physiological arousal associated with anxiety. Four counts in, hold four counts, out four counts (box breathing) is a simple technique that can interrupt anxious activation in real time.

Limiting Stimulants

Caffeine, especially in high amounts, amplifies anxiety. During cannabis withdrawal, when anxiety is already elevated, reducing or eliminating caffeine can meaningfully reduce symptom intensity.

Sleep Priority

Sleep deprivation dramatically worsens anxiety. Because sleep is disrupted during withdrawal, protecting sleep quality as much as possible through consistent timing, a dark and cool room, and no screens before bed reduces the anxiety intensity the next day.

What Helps Anxiety Disorder

If anxiety persists at four to six weeks after stopping cannabis and is interfering with your daily life, a mental health evaluation is appropriate. Effective treatments for anxiety disorders include:

• Cognitive behavioral therapy (CBT): The best-evidence psychological treatment for most anxiety disorders. It helps identify and change the thought patterns that drive anxious responses.
• SSRIs and SNRIs: First-line medications for most anxiety disorders. Commonly prescribed medications include sertraline (Zoloft), escitalopram (Lexapro), and venlafaxine (Effexor).
• Buspirone: A non-habit-forming anxiolytic that is useful for generalized anxiety. It takes two to four weeks to reach full effect.

Benzodiazepines like Xanax or Klonopin are also used for anxiety but carry their own dependence risk. Given that you have already been managing dependence through cannabis, discussing this risk with your doctor is especially worthwhile before starting benzodiazepines.

Treating Both at Once

In many cases, the answer is not either/or. You can have cannabis withdrawal anxiety that is real and temporary, and an underlying anxiety disorder that has been masked and needs treatment. Both are true at the same time.

The practical approach is to stop cannabis, manage through the withdrawal symptoms with behavioral tools, and then get a proper psychiatric evaluation at four to six weeks. Bring your honest history: how long you used cannabis, what it was doing for you emotionally, and what your anxiety looked like before you started. That context helps a clinician make an accurate diagnosis and a treatment plan that addresses your actual situation rather than a simplified version of it.